AMMI Canada Practice Point: Updated recommendations for treatment of adults with symptomatic COVID-19 in 2023-2024.

Autor: Grant JM; Divisions of Medical Microbiology and Infectious Diseases, University of British Columbia, Vancouver, British Columbia, Canada., Lam J; Division of Infectious Diseases, Department of Medicine, University of California, Los Angeles, California, USA., Goyal SV; Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada., Lother S; Sections of Infectious Diseases and Critical Care, University of Manitoba, Manitoba, Canada., Kassim SS; Department of Family Medicine, University of Manitoba, Manitoba, Canada., Lee SB; Division of Infectious Diseases, University of Saskatchewan, Saskatoon, Saskatchewan, Canada., Chan J; Division of Infectious Diseases and Immunology, Department of Medicine, NYU Grossman School of Medicine, New York, USA., Girouard G; Centre hospitalier universitaire Dr-Georges-L.-Dumont Vitalité Health Network, Moncton, New Brunswick, Canada., Barrett L; Infectious Diseases NSHA, Dalhousie University, Halifax, Nova Scotia, Canada., Takaya S; Division of Infectious Diseases, University of Saskatchewan, Saskatoon, Saskatchewan, Canada., Piszczek J; Department of Pharmacy, Royal Jubilee Hospital, Victoria, British Columbia, Canada., Vinh DC; Division of Infectious Diseases, Department of Medicine; Division of Medical Microbiology, Department of Laboratory Medicine, McGill University Health Centre, Montreal, Quebec, Canada., Findlater AR; Department of Medicine, McMaster University, Hamilton, Ontario, Canada., Saxinger L; Division of Infectious Diseases, University of Alberta, Edmonton, Alberta, Canada.

Publikováno v: Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada [J Assoc Med Microbiol Infect Dis Can] 2024 Jan 16; Vol. 8 (4), pp. 245-252. Date of Electronic Publication: 2024 Jan 16 (Print Publication: 2024).

Infectious diseases, comorbidities and outcomes in hospitalized people who inject drugs (PWID)

Autor: Lim J; Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada., Pavalagantharajah S; Department of Medicine, McMaster University, Hamilton, Ontario, Canada., Verschoor CP; Health Sciences North Research Institute, Sudbury, Ontario, Canada., Lentz E; Department of Medicine, McMaster University, Hamilton, Ontario, Canada., Loeb M; Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada., Levine M; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada., Smieja M; Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada., Mbuagbaw L; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada., Kalina D; Department of Medicine, McMaster University, Hamilton, Ontario, Canada., Tarride JE; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.; Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Ontario, Canada., O'Shea T; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Population Health Research Institute, Hamilton, Ontario, Canada., Cvetkovic A; Department of Medicine, McMaster University, Hamilton, Ontario, Canada., van Gaalen S; Department of Family Medicine, Queen's University, Kingston, Ontario, Canada., Findlater AR; Department of Medicine, McMaster University, Hamilton, Ontario, Canada., Lennox R; Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada., Bassim C; Department of Medicine, McMaster University, Hamilton, Ontario, Canada., Lokker C; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada., Alvarez E; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.; Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Ontario, Canada.

Publikováno v: PloS one [PLoS One] 2022 Apr 20; Vol. 17 (4), pp. e0266663. Date of Electronic Publication: 2022 Apr 20 (Print Publication: 2022).

Seroprevalence of West Nile virus in Saskatchewan's Five Hills Health Region, 2003.

Autor: Schellenberg TL; Department of Public Health Services, Five Hills Health Region, Moose Jaw, SK. tschell@fhhr.ca, Anderson ME, Drebot MA, Vooght MT, Findlater AR, Curry PS, Campbell CA, Osei WD

Publikováno v: Canadian journal of public health = Revue canadienne de sante publique [Can J Public Health] 2006 Sep-Oct; Vol. 97 (5), pp. 369-73.

West Nile virus in Canada: ever-changing, but here to stay.

Autor: Zheng, H., Drebot, M. A., Coulthart, M. B.

Publikováno v: Canada Communicable Disease Report; 5/15/2014, Vol. 40 Issue 10, p173-177, 5p

Zoonoses: Infections Affecting Humans and Animals

Autor: Andreas Sing

This second fully revised and extended edition of “Zoonoses - Infections Affecting Humans and Animals” covers the most important pathogens impacting both human and animal public health and debates current developments in this interdisciplinary fi